Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Attendees of Manchester's Lung Health Check pilot express a preference for community-based lung cancer screening.

Balata H, Tonge J, Barber PV, Colligan D, Elton P, Evison M, Kirwan M, Novasio J, Sharman A, Slevin K, Taylor S, Waplington S, Booton R, Crosbie PA.

Thorax. 2019 Dec;74(12):1176-1178. doi: 10.1136/thoraxjnl-2018-212601. Epub 2019 Sep 3.

PMID:
31481631
2.

Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.

Crosbie PA, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D, Duerden R, Eaglesfield J, Edwards T, Elton P, Foster J, Greaves M, Hayler G, Higgins C, Howells J, Irion K, Karunaratne D, Kelly J, King Z, Lyons J, Manson S, Mellor S, Miller D, Myerscough A, Newton T, O'Leary M, Pearson R, Pickford J, Sawyer R, Screaton NJ, Sharman A, Simmons M, Smith E, Taylor B, Taylor S, Walsham A, Watts A, Whittaker J, Yarnell L, Threlfall A, Barber PV, Tonge J, Booton R.

Thorax. 2019 Jul;74(7):700-704. doi: 10.1136/thoraxjnl-2018-212547. Epub 2018 Nov 12.

3.

"To know or not to know…?" Push and pull in ever smokers lung screening uptake decision-making intentions.

Tonge JE, Atack M, Crosbie PA, Barber PV, Booton R, Colligan D.

Health Expect. 2019 Apr;22(2):162-172. doi: 10.1111/hex.12838. Epub 2018 Oct 5.

4.

Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester.

Crosbie PA, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D, Duerden R, Eaglesfield J, Edwards T, Elton P, Foster J, Greaves M, Hayler G, Higgins C, Howells J, Irion K, Karunaratne D, Kelly J, King Z, Manson S, Mellor S, Miller D, Myerscough A, Newton T, O'Leary M, Pearson R, Pickford J, Sawyer R, Screaton NJ, Sharman A, Simmons M, Smith E, Taylor B, Taylor S, Walsham A, Watts A, Whittaker J, Yarnell L, Threlfall A, Barber PV, Tonge J, Booton R.

Thorax. 2019 Apr;74(4):405-409. doi: 10.1136/thoraxjnl-2017-211377. Epub 2018 Feb 13.

PMID:
29440588
5.

Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.

Evison M, Crosbie PA, Califano R, Summers Y, Martin J, Barber PV, Booton R.

J Bronchology Interv Pulmonol. 2015 Apr;22(2):114-20. doi: 10.1097/LBR.0000000000000154.

PMID:
25887006
6.

Achieving a tissue diagnosis in PS3 patients with advanced lung cancer: what are the safety and diagnostic outcomes with EBUS?

Al-Najjar H, Evison M, Crosbie PA, Martin J, Barber PV, Booton R.

Lung Cancer. 2015 May;88(2):236-7. doi: 10.1016/j.lungcan.2015.03.001. Epub 2015 Mar 9. No abstract available.

PMID:
25783565
7.

A study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA.

Evison M, Crosbie PA, Morris J, Martin J, Barber PV, Booton R.

BMJ Open Respir Res. 2014 May 31;1(1):e000040. doi: 10.1136/bmjresp-2014-000040. eCollection 2014. Erratum in: BMJ Open Respir Res. 2014;1(1):e000040corr1.

8.

Nodal staging in lung cancer: a risk stratification model for lymph nodes classified as negative by EBUS-TBNA.

Evison M, Morris J, Martin J, Shah R, Barber PV, Booton R, Crosbie PA.

J Thorac Oncol. 2015 Jan;10(1):126-33. doi: 10.1097/JTO.0000000000000348.

9.

Can computed tomography characteristics predict outcomes in patients undergoing radial endobronchial ultrasound-guided biopsy of peripheral lung lesions?

Evison M, Crosbie PA, Morris J, Martin J, Barber PV, Booton R.

J Thorac Oncol. 2014 Sep;9(9):1393-7. doi: 10.1097/JTO.0000000000000249.

10.

EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes.

Evison M, Crosbie PA, Martin J, Bishop P, Doran H, Joseph L, Chaturvedi A, Barber PV, Booton R.

J Thorac Oncol. 2014 Mar;9(3):370-6. doi: 10.1097/JTO.0000000000000085.

11.

Topographical study of O(6)-alkylguanine DNA alkyltransferase repair activity and N7-methylguanine levels in resected lung tissue.

Crosbie PA, Harrison K, Shah R, Watson AJ, Agius R, Barber PV, Margison GP, Povey AC.

Chem Biol Interact. 2013 Jul 5;204(2):98-104. doi: 10.1016/j.cbi.2013.04.013. Epub 2013 May 9.

PMID:
23665414
12.

Elevated N3-methylpurine-DNA glycosylase DNA repair activity is associated with lung cancer.

Crosbie PA, Watson AJ, Agius R, Barber PV, Margison GP, Povey AC.

Mutat Res. 2012 Apr 1;732(1-2):43-6. doi: 10.1016/j.mrfmmm.2012.01.001. Epub 2012 Jan 14.

PMID:
22266085
13.

British Thoracic Society guideline for advanced diagnostic and therapeutic flexible bronchoscopy in adults.

Du Rand IA, Barber PV, Goldring J, Lewis RA, Mandal S, Munavvar M, Rintoul RC, Shah PL, Singh S, Slade MG, Woolley A; British Thoracic Society Interventional Bronchoscopy Guideline Group.

Thorax. 2011 Nov;66 Suppl 3:iii1-21. doi: 10.1136/thoraxjnl-2011-200713. No abstract available.

PMID:
21987439
14.

Summary of the British Thoracic Society guidelines for advanced diagnostic and therapeutic flexible bronchoscopy in adults.

Du Rand IA, Barber PV, Goldring J, Lewis RA, Mandal S, Munavvar M, Rintoul RC, Shah PL, Singh S, Slade MG, Woolley A; BTS Interventional Bronchoscopy Guideline Group.

Thorax. 2011 Nov;66(11):1014-5. doi: 10.1136/thoraxjnl-2011-201052.

PMID:
22003155
15.

GSTM1 copy number and lung cancer risk.

Crosbie PA, Barber PV, Harrison KL, Gibbs AR, Agius RM, Margison GP, Povey AC.

Mutat Res. 2009 May 12;664(1-2):1-5. doi: 10.1016/j.mrfmmm.2009.01.006. Epub 2009 Feb 4.

PMID:
19428374
16.

Association between lung cancer risk and single nucleotide polymorphisms in the first intron and codon 178 of the DNA repair gene, O6-alkylguanine-DNA alkyltransferase.

Crosbie PA, McGown G, Thorncroft MR, O'Donnell PN, Barber PV, Lewis SJ, Harrison KL, Agius RM, Santibáñez-Koref MF, Margison GP, Povey AC.

Int J Cancer. 2008 Feb 15;122(4):791-5.

17.

No association between N7-methyldeoxyguanosine and 8-oxodeoxyguanosine levels in human lymphocyte DNA.

Harrison KL, Crosbie PA, Agius RM, Barber PV, Carus M, Margison GP, Povey AC.

Mutat Res. 2006 Aug 30;600(1-2):125-30. Epub 2006 Jun 12.

PMID:
16765387
18.

Quantitative trait locus analysis reveals two intragenic sites that influence O6-alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cells.

Margison GP, Heighway J, Pearson S, McGown G, Thorncroft MR, Watson AJ, Harrison KL, Lewis SJ, Rohde K, Barber PV, O'Donnell P, Povey AC, Santibáñez-Koref MF.

Carcinogenesis. 2005 Aug;26(8):1473-80. Epub 2005 Apr 14.

PMID:
15831531
19.

The development of the first nurse-led bronchoscopy post in the United Kingdom.

Barber PV, Martin J, O'Donnell PN.

Respir Med. 2004 Jun;98(6):504-8.

20.

Training for nurse-led bronchoscopy.

O'Donnell PN, Barber PV, Martin JM.

Med Educ. 2004 May;38(5):552-3. No abstract available.

PMID:
15107098
21.

Associations between smoking, GST genotypes and N7-methylguanine levels in DNA extracted from bronchial lavage cells.

Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC.

Mutat Res. 2004 Apr 11;559(1-2):11-8.

PMID:
15066569
22.

Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic.

Lewis SJ, Cherry NM, McL Niven R, Barber PV, Wilde K, Povey AC.

Biomarkers. 2003 May-Aug;8(3-4):218-28.

PMID:
12944174
23.

GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk.

Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC.

Cancer Lett. 2002 Jun 28;180(2):165-71.

PMID:
12175548
24.

Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population.

Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC.

Lung Cancer. 2001 Nov;34(2):177-83.

PMID:
11679176
25.

Treatment of endobronchial metastases with intraluminal radiotherapy.

Quantrill SJ, Burt PA, Barber PV, Stout R.

Respir Med. 2000 Apr;94(4):369-72.

26.

Gonadotrophin-releasing hormone analogues: a novel treatment for premenstrual asthma.

Murray RD, New JP, Barber PV, Shalet SM.

Eur Respir J. 1999 Oct;14(4):966-7.

27.

Association between O6-alkylguanine-DNA-alkyltransferase activity in peripheral blood lymphocytes and bronchial epithelial cells.

O'Donnell PN, Barber PV, Margison GP, Povey AC.

Cancer Epidemiol Biomarkers Prev. 1999 Jul;8(7):641-5.

28.

Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus.

Gollins SW, Ryder WD, Burt PA, Barber PV, Stout R.

Radiother Oncol. 1996 May;39(2):105-16.

PMID:
8735477
29.
30.

High dose rate intraluminal radiotherapy for carcinoma of the bronchus: outcome of treatment of 406 patients.

Gollins SW, Burt PA, Barber PV, Stout R.

Radiother Oncol. 1994 Oct;33(1):31-40.

PMID:
7533304
31.

Intraluminal irradiation for the palliation of lung cancer with the high dose rate micro-Selectron.

Burt PA, O'Driscoll BR, Notley HM, Barber PV, Stout R.

Thorax. 1990 Oct;45(10):765-8.

32.

A clinicopathological study of the paraneoplastic neuromuscular syndromes associated with lung cancer.

Gomm SA, Thatcher N, Barber PV, Cumming WJ.

Q J Med. 1990 Jun;75(278):577-95.

PMID:
2171009
33.

Pleural myxoma associated with a pulmonary squamous cell carcinoma.

Hasleton PS, Langdale-Brown B, Rahman A, Smyrniou N, Barber PV.

Respir Med. 1989 Sep;83(5):443-4. No abstract available.

PMID:
2616831
34.

Atraumatic suppurative mediastinitis and purulent pericarditis due to Eikenella corrodens.

Hardy CC, Raza SN, Isalska B, Barber PV.

Thorax. 1988 Jun;43(6):494-5.

35.

Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer.

Thatcher N, Cerny T, Stout R, Anderson H, Barber PV, Wolstenholme RJ, Barnes P, Deiraniya A.

Cancer. 1987 Nov 15;60(10):2382-7.

PMID:
2822217
36.

Expression of epidermal growth factor receptor (EGF-R) in human lung tumours.

Cerny T, Barnes DM, Hasleton P, Barber PV, Healy K, Gullick W, Thatcher N.

Br J Cancer. 1986 Aug;54(2):265-9.

38.

Three months' treatment with cyclophosphamide, VP-16-213 followed by methotrexate and thoracic radiotherapy for small cell lung cancer.

Thatcher N, James RD, Steward WP, Barber PV, Feinmann D, Lawson BA, Carroll KB.

Cancer. 1985 Sep 15;56(6):1332-6.

PMID:
2992736
39.

Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.

Thatcher N, Honeybourne D, Wagstaff J, Carroll KB, Barber PV, Morrison JB, Crowther D.

Br J Dis Chest. 1984 Jan;78(1):89-97.

PMID:
6318791
40.

Stress fracture of the first rib.

Rademaker M, Redmond AD, Barber PV.

Thorax. 1983 Apr;38(4):312-3. No abstract available.

41.

Hypertrophic osteoarthropathy: two unusual causes.

Barber PV, Lechler R.

Postgrad Med J. 1983 Apr;59(690):254-5.

42.
43.

A therapeutic comparison of ipratropium bromide and salbutamol in asthmatic patients.

Bell R, Sahay JN, Barber PV, Chatterjee SS, Cox G.

Curr Med Res Opin. 1982;8(4):242-6.

PMID:
6217949
44.

Incidence of thyroid disease in cases of hypertrophic cardiomyopathy.

Bell R, Barber PV, Bray CL, Beton DC.

Br Heart J. 1978 Nov;40(11):1306-9.

45.

Erythema gyratum repens with pulmonary tuberculosis.

Barber PV, Doyle L, Vickers DM, Hubbard H.

Br J Dermatol. 1978 Apr;98(4):465-8.

PMID:
638054
46.

Bacterial septicaemia with multiple organisms complicating influenzal pneumonia.

Barber PV, Stanbridge TN.

Br Med J. 1977 Jun 11;1(6075):1511-2. No abstract available.

47.

A comparison of ipratropium bromide, deptropine citrate and placebo in asthma and chronic bronchitis.

Barber PV, Chatterjee SS, Scott R.

Br J Dis Chest. 1977 Apr;71(2):101-4.

PMID:
140698
48.
49.

Recurrent hormone dependent chorea: effects of oestrogens and progestogens.

Barber PV, Arnold AG, Evans G.

Clin Endocrinol (Oxf). 1976 May;5(3):291-3.

PMID:
954223
50.

Retrosternal goitre presenting as bleeding oesophageal varices.

Barber PV, Edwards JD, Enoch BA, Shafiq M, Vallon AG.

Br Med J. 1976 Mar 6;1(6009):564. No abstract available.

Supplemental Content

Loading ...
Support Center